NCT07195305View on ClinicalTrials.gov

Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding

NANot yet recruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
Abnormal Uterine Bleeding Due to Adenomyosis (Disorder)
Interventions
PROCEDURE

Radiofrequency endometrial ablation

Radiofrequency endometrial ablation

PROCEDURE

Uterine artery embolization

Uterine artery embolization

PROCEDURE

Hysterectomy

Hysterectomy

Trial Locations (1)

Unknown

CHU Bordeaux, Bordeaux

All Listed Sponsors
collaborator

French Ministry of Social Affairs and Health

UNKNOWN

lead

University Hospital, Bordeaux

OTHER

NCT07195305 - Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding | Biotech Hunter | Biotech Hunter